Implantable defibrillators in long QT syndrome, brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy

Mustafa Dohadwala, Mark S. Link

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Sudden death is often the first manifestation in inherited cardiac arrhythmia syndromes. Patients with long QT syndrome who have an episode of syncope while on beta-blockade should be offered an implantable cardioverter-defibrillator (ICD). In Brugada syndrome and hypertrophic cardiomyopathy, ICDs are often the most effective treatment of primary and secondary prevention of cardiac arrest. Risk stratification is crucial in identifying those at greatest risk to provide lifesaving therapy with an ICD while avoiding complications in those unlikely to receive benefit.

Original languageEnglish (US)
Pages (from-to)305-318
Number of pages14
JournalCardiology Clinics
Volume32
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Arrhythmogenic Right Ventricular Dysplasia
Brugada Syndrome
Long QT Syndrome
Implantable Defibrillators
Hypertrophic Cardiomyopathy
Syncope
Primary Prevention
Sudden Death
Secondary Prevention
Heart Arrest
Cardiac Arrhythmias
Therapeutics

Keywords

  • Arrhythmogenic right ventricular cardiomyopathy
  • Brugada syndrome
  • Channelopathy
  • Genetic syndrome
  • Hypertrophic cardiomyopathy
  • Long QT syndrome
  • Sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Implantable defibrillators in long QT syndrome, brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy. / Dohadwala, Mustafa; Link, Mark S.

In: Cardiology Clinics, Vol. 32, No. 2, 01.01.2014, p. 305-318.

Research output: Contribution to journalReview article

@article{47df1faa4c8e4735b931bf5b24d4af16,
title = "Implantable defibrillators in long QT syndrome, brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy",
abstract = "Sudden death is often the first manifestation in inherited cardiac arrhythmia syndromes. Patients with long QT syndrome who have an episode of syncope while on beta-blockade should be offered an implantable cardioverter-defibrillator (ICD). In Brugada syndrome and hypertrophic cardiomyopathy, ICDs are often the most effective treatment of primary and secondary prevention of cardiac arrest. Risk stratification is crucial in identifying those at greatest risk to provide lifesaving therapy with an ICD while avoiding complications in those unlikely to receive benefit.",
keywords = "Arrhythmogenic right ventricular cardiomyopathy, Brugada syndrome, Channelopathy, Genetic syndrome, Hypertrophic cardiomyopathy, Long QT syndrome, Sudden death",
author = "Mustafa Dohadwala and Link, {Mark S.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.ccl.2013.11.003",
language = "English (US)",
volume = "32",
pages = "305--318",
journal = "Cardiology Clinics",
issn = "0733-8651",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Implantable defibrillators in long QT syndrome, brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy

AU - Dohadwala, Mustafa

AU - Link, Mark S.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Sudden death is often the first manifestation in inherited cardiac arrhythmia syndromes. Patients with long QT syndrome who have an episode of syncope while on beta-blockade should be offered an implantable cardioverter-defibrillator (ICD). In Brugada syndrome and hypertrophic cardiomyopathy, ICDs are often the most effective treatment of primary and secondary prevention of cardiac arrest. Risk stratification is crucial in identifying those at greatest risk to provide lifesaving therapy with an ICD while avoiding complications in those unlikely to receive benefit.

AB - Sudden death is often the first manifestation in inherited cardiac arrhythmia syndromes. Patients with long QT syndrome who have an episode of syncope while on beta-blockade should be offered an implantable cardioverter-defibrillator (ICD). In Brugada syndrome and hypertrophic cardiomyopathy, ICDs are often the most effective treatment of primary and secondary prevention of cardiac arrest. Risk stratification is crucial in identifying those at greatest risk to provide lifesaving therapy with an ICD while avoiding complications in those unlikely to receive benefit.

KW - Arrhythmogenic right ventricular cardiomyopathy

KW - Brugada syndrome

KW - Channelopathy

KW - Genetic syndrome

KW - Hypertrophic cardiomyopathy

KW - Long QT syndrome

KW - Sudden death

UR - http://www.scopus.com/inward/record.url?scp=84899989344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899989344&partnerID=8YFLogxK

U2 - 10.1016/j.ccl.2013.11.003

DO - 10.1016/j.ccl.2013.11.003

M3 - Review article

C2 - 24793806

AN - SCOPUS:84899989344

VL - 32

SP - 305

EP - 318

JO - Cardiology Clinics

JF - Cardiology Clinics

SN - 0733-8651

IS - 2

ER -